XML 48 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business Segments
 12 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280. Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.
  
The tables below summarize information about our operating and reportable segments.

 Year Ended March 31, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$958,260 $167,097 $1,125,357 
Cost of sales429,361 71,548 500,909 
Gross profit528,899 95,549 624,448 
Advertising and marketing131,494 21,821 153,315 
Contribution margin$397,405 $73,728 471,133 
Other operating expenses 128,704 
Operating income $342,429 
*Intersegment revenues of $3.7 million were eliminated from the North American OTC Healthcare segment.

 Year Ended March 31, 2023
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$973,774 $153,951 $1,127,725 
Cost of sales441,844 60,587 502,431 
Gross profit531,930 93,364 625,294 
Advertising and marketing123,926 21,135 145,061 
Contribution margin$408,004 $72,229 480,233 
Other operating expenses**502,648 
Operating loss$(22,415)
* Intersegment revenues of $4.3 million were eliminated from the North American OTC Healthcare segment.
**Other operating expenses for the year ended March 31, 2023 includes a tradename impairment charge of $321.4 million and a goodwill impairment charge of $48.8 million.

 Year Ended March 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues* $967,881 $118,931 $1,086,812 
Cost of sales419,162 47,004 466,166 
Gross profit548,719 71,927 620,646 
Advertising and marketing138,714 18,629 157,343 
Contribution margin$410,005 $53,298 463,303 
Other operating expenses133,384 
Operating income$329,919 
*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.
The tables below summarize information about our segment revenues from similar product groups.

Year Ended March 31, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$111,996 $5,455 $117,451 
Cough & Cold93,575 25,445 119,020 
Women's Health217,103 23,318 240,421 
Gastrointestinal160,889 70,721 231,610 
Eye & Ear Care156,553 22,870 179,423 
Dermatologicals123,288 5,814 129,102 
Oral Care83,212 13,093 96,305 
Other OTC11,644 381 12,025 
Total segment revenues$958,260 $167,097 $1,125,357 

Year Ended March 31, 2023
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$116,582 $2,680 $119,262 
Cough & Cold100,218 26,770 126,988 
Women's Health231,754 19,597 251,351 
Gastrointestinal156,957 69,626 226,583 
Eye & Ear Care151,879 19,197 171,076 
Dermatologicals119,822 3,919 123,741 
Oral Care85,542 12,085 97,627 
Other OTC11,020 77 11,097 
Total segment revenues$973,774 $153,951 $1,127,725 

Year Ended March 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$117,868 $1,455 $119,323 
Cough & Cold86,855 20,225 107,080 
Women's Health249,136 15,373 264,509 
Gastrointestinal152,191 52,368 204,559 
Eye & Ear Care149,454 13,995 163,449 
Dermatologicals117,173 3,213 120,386 
Oral Care85,239 12,282 97,521 
Other OTC9,965 20 9,985 
Total segment revenues$967,881 $118,931 $1,086,812 
Our total segment revenues by geographic area are as follows:
Year Ended March 31,
202420232022
United States$886,470 $953,222 $910,106 
Rest of world238,887 174,503 176,706 
Total$1,125,357 $1,127,725 $1,086,812 

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:

March 31, 2024
(In thousands)
North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Goodwill$498,936 $28,797 $527,733 
Intangible assets 
Indefinite-lived2,092,853 74,309 2,167,162 
Finite-lived135,932 17,489 153,421 
Intangible assets, net2,228,785 91,798 2,320,583 
Total$2,727,721 $120,595 $2,848,316 

March 31, 2023
(In thousands)
North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Goodwill$498,936 $28,617 $527,553 
Intangible assets 
Indefinite-lived2,092,852 76,050 2,168,902 
Finite-lived154,552 18,439 172,991 
Intangible assets, net2,247,404 94,489 2,341,893 
Total$2,746,340 $123,106 $2,869,446 

Our goodwill and intangible assets by geographic area are as follows:
Year Ended March 31,
20242023
United States$2,727,721 $2,746,340 
Rest of world120,595 123,106 
Total$2,848,316 $2,869,446